Contract research organisation (CRO) Syneos Health has agreed to be acquired by a group of investors, in the second multibillion-dollar takeover of a pharma outsourcing bu
The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.